... and set up Czech center | Chemical & Engineering News
Volume 84 Issue 30 | p. 17 | Concentrates
Issue Date: July 24, 2006

... and set up Czech center

Department: Business

Gilead plans to provide $1.1 million annually for five years to the Institute of Organic Chemistry & Biochemistry at the Academy of Sciences of the Czech Republic (IOCB) to help establish a research facility. Gilead has licensing agreements with IOCB and the Rega Institute for Medical Research at Belgium's Katholic University dating back to 1991 for a range of nucleotide analog compounds and structures. Several of them have been developed by Gilead, resulting in the HIV treatment Viread and other drugs.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment